| Gene symbol | CD1A | Synonyms | CD1, FCB6, HTA1, R4, T6 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q23.1 | dbXrefs | |
| Description | CD1a molecule | ||||
| GTO ID | GTC3304 |
| Trial ID | NCT05679895 |
| Disease | T-Cell Lymphoblastic Leukemia/Lymphoma |
| Altered gene | CD1a |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD1a CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL |
| Year | 2023 |
| Country | Spain |
| Company sponsor | OneChain Immunotherapeutics |
| Other ID(s) | OC-01-21001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||